Hikma Pharmaceuticals Plc Notice of Results (9302Q)
March 03 2016 - 4:25AM
UK Regulatory
TIDMHIK
RNS Number : 9302Q
Hikma Pharmaceuticals Plc
03 March 2016
Notice of Results
LONDON, UK, 3 March, 2016 - Hikma Pharmaceuticals PLC ("Hikma")
(LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY), (rated Ba1 Moody's /
BB+ S&P, both stable), the fast growing pharmaceuticals
company, will announce its annual financial results for the year
ended 31 December 2015 on Wednesday 16 March 2016.
A presentation and webcast for analysts will be held at 9.30am
GMT at FTI Consulting, 200 Aldersgate, Aldersgate Street, London,
EC1A 4HD.
To join via conference call please dial: +44 (0) 20 3003
2666
UK Toll--Free Number: 0808 109 0700
The results presentation and a webcast recording of the event
will be available on the Company's website at www.hikma.com or
http://cache.merchantcantos.com/webcast/webcaster/4000/7464/16532/58467/Lobby/default.htm
Playback facility:
A playback of the conference call will be available up to 7 days
after the presentation.
UK & International Number: +44 (0) 20 8196 1998
UK Toll-Free Number: 0800 633 8453
Replay PIN code: 8022823#
-Ends-
Enquiries
Hikma Pharmaceuticals PLC
Susan Ringdal, VP Corporate +44 (0)20 7399 2760/+44
Strategy and Investor Relations 7776 477050
Zeena Murad, Investor Relations +44 (0)20 7399 2768/+44
Manager 7771 665277
FTI Consulting
Ben Atwell/Matthew Cole +44 (0)20 3727 1000
About Hikma
Hikma Pharmaceuticals PLC is a fast growing multinational group
focused on developing, manufacturing and marketing a broad range of
both branded and non-branded generic and in-licensed products.
Hikma operates through three businesses: "Branded", "Injectables"
and "Generics", based principally in the Middle East and North
Africa ("MENA"), where it is a market leader, the United States and
Europe. In 2014, Hikma achieved revenues of US$1,489 million and
profit attributable to shareholders of US$299 million.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORZMGGFLFGGVZG
(END) Dow Jones Newswires
March 03, 2016 04:25 ET (09:25 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024